Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Learning from disease registries during a pandemic: Moving toward an international federation of patient registries.
Wall D, Alhusayen R, Arents B, Apfelbacher C, Balogh EA, Bokhari L, Bloem M, Bosma AL, Burton T, Castelo-Soccio L, Fagan N, Feldman SR, Fletcher G, Flohr C, Freeman E, French LE, Griffiths CEM, Hruza GJ, Ingram JR, Kappelman MD, Lara-Corrales I, Lim HW, Meah N, McMahon DE, Mahil SK, McNicoll I, Musters A, Naik HB, Sinclair R, Smith CH, Spuls P, Tobin DJ, York K, Irvine AD. Wall D, et al. Among authors: burton t. Clin Dermatol. 2021 May-Jun;39(3):467-478. doi: 10.1016/j.clindermatol.2021.01.018. Epub 2021 Apr 6. Clin Dermatol. 2021. PMID: 34518006 Free PMC article.
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis.
Drucker AM, Ellis AG, Bohdanowicz M, Mashayekhi S, Yiu ZZN, Rochwerg B, Di Giorgio S, Arents BWM, Burton T, Spuls PI, Küster D, Siegels D, Schmitt J, Flohr C. Drucker AM, et al. Among authors: burton t. JAMA Dermatol. 2020 Jun 1;156(6):659-667. doi: 10.1001/jamadermatol.2020.0796. JAMA Dermatol. 2020. PMID: 32320001 Free PMC article.
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registry.
Musters AH, Broderick C, Prieto-Merino D, Chiricozzi A, Damiani G, Peris K, Dhar S, De A, Freeman E, Arents BWM, Burton T, Bosma ALL, Chi CC, Fletcher G, Drucker AM, Kabashima K, de Monchy EF, Panda M, Wall DR, Vestergaard C, Mahé E, Bonzano L, Kattach L, Napolitano M, Ordoñez-Rubiano MF, Haufe E, Patruno C, Irvine AD, Spuls PI, Flohr C. Musters AH, et al. Among authors: burton t. J Eur Acad Dermatol Venereol. 2023 Feb;37(2):365-381. doi: 10.1111/jdv.18613. Epub 2022 Oct 12. J Eur Acad Dermatol Venereol. 2023. PMID: 36169355 Free PMC article.
Topical steroid withdrawal syndrome: time to bridge the gap.
Cotter C, Burton T, Proctor A, Moss C, Flohr C. Cotter C, et al. Among authors: burton t. Br J Dermatol. 2022 Nov;187(5):780-781. doi: 10.1111/bjd.21770. Epub 2022 Aug 20. Br J Dermatol. 2022. PMID: 35833942 No abstract available.
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative.
Leshem YA, Chalmers JR, Apfelbacher C, Katoh N, Gerbens LAA, Schmitt J, Spuls PI, Thomas KS, Howells L, Williams HC, Simpson EL; Harmonising Outcome Measures for Eczema (HOME) initiative. Leshem YA, et al. JAMA Dermatol. 2022 Dec 1;158(12):1429-1435. doi: 10.1001/jamadermatol.2022.4211. JAMA Dermatol. 2022. PMID: 36223090
Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP).
Howells LM, Chalmers JR, Gran S, Ahmed A, Apfelbacher C, Burton T, Howie L, Lawton S, Ridd MJ, Rogers NK, Sears AV, Spuls P, von Kobyletzki L, Thomas KS. Howells LM, et al. Among authors: burton t. Br J Dermatol. 2020 Sep;183(3):524-536. doi: 10.1111/bjd.18780. Epub 2020 Feb 20. Br J Dermatol. 2020. PMID: 31794074 Free PMC article.
Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
Thomas KS, Apfelbacher CA, Chalmers JR, Simpson E, Spuls PI, Gerbens LAA, Williams HC, Schmitt J, Gabes M, Howells L, Stuart BL, Grinich E, Pawlitschek T, Burton T, Howie L, Gadkari A, Eckert L, Ebata T, Boers M, Saeki H, Nakahara T, Katoh N. Thomas KS, et al. Among authors: burton t. Br J Dermatol. 2021 Jul;185(1):139-146. doi: 10.1111/bjd.19751. Epub 2021 Feb 8. Br J Dermatol. 2021. PMID: 33393074 Free PMC article.
Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
Thomas KS, Apfelbacher CA, Chalmers JR, Simpson E, Spuls PI, Gerbens LAA, Williams HC, Schmitt J, Gabes M, Howells L, Stuart BL, Grinich E, Pawlitschek T, Burton T, Howie L, Gadkari A, Eckert L, Ebata T, Boers M, Saeki H, Nakahara T, Katoh N. Thomas KS, et al. Among authors: burton t. Br J Dermatol. 2020 Nov 11. doi: 10.1111/bjd.19673. Online ahead of print. Br J Dermatol. 2020. PMID: 33179283
427 results